Get started

Oversold

KNHBF: Could this be the start of the Next +100pct Rally? ===================== Our New Pick is: KNHBF Current Price: $0.25 Investor Presentation ======================== Members, Earlier this week, we told you that we were looking for the perfect trade idea that could deliver easy profits during this brutal bear market. After scanning the market for quite some time, we've decided not to take any chances, and just go with a company that has proven itself to be a winner each and every time we've alerted it to our members. Please turn your immediate to attention back to our #1 cannabis play of 2018 KNHBF (ICC International Cannabis Corp.) We plan on ending this 2019 on a high-note with this past +100% winner! We first brought KNHBF to your attention back on September 27 when it was flying under the radar at just $0.44 per share. In less than two week's time, shares of KNHBF rallied as high as $0.90, representing multi-day gains of up to +104.55% for our members. We are just as excited about KNHBF now as we were back in late September. In fact, the upside is even more attractive now. Shares of KNHBF traded down to $0.25 yesterday, creating the perfect buying opportunity for those looking to cash in on the cannabis boom at a ground floor price. We've been keeping a close eye on this red-hot cannabis play, and we believe that right now could be the perfect entry point for those looking for a piece of this cannabis company committed to growth Here's why... On Oct. 17, Canada becomes the second and largest country with a legal national marijuana marketplace. KNHBF has been issued the FIRST EVER medical cannabis cultivation license by the Greek government. Broke ground on Colombian Centre of Excellence for Cannabis Propagation; Marking Initialization of 10-Hectare Cannabis Park Announced the creation of the world’s first fully electronic cannabis marketplace through a partnership with GreenTree International, the parent company of Amercanex, which operates a secure Electronic Cannabis Market (ECM) called ACExchange. Completed 100% Acquisition of Enigma Unipessoal LDA - a company who controls one of the first hemp licenses issued in Portugal Entered into a definitive agreement to acquire 100 percent of Balkan Cannabis Corp (“Balkan Cannabis”). Balkan Cannabis controls Macedonian medical Cannabis cultivation and extraction licenses, as well as Bulgarian medical Cannabis and hemp cultivation licenses. Increased their European distribution footprint by over 1,300 pharmacies As you can see KNHBF is deeply committed to strengthening its grip on the European cannabis market. With a population twice the size of the US and Canada combined, and a cannabis market still in its relative infancy, Europe presents an enormous opportunity. KNHBF has been dropping big news almost daily, and we would not be surprised if the Company announced another major milestone today. This could be one of your last chances to start a position in KNHBF for a under $1 per share.... That being said, we are urging all members to start their research on this past +100% winner immediately, and be ready to take action this morning at 9:30AM EST! About ICC International Cannabis Corp. Via its diversified portfolio of companies and subsidiaries, ICC International Cannabis intends to further establish itself as a international Cannabis industry consolidation platform. The Company’s mission is to inspire holistic wellness by augmenting the design, development and production of the world’s most innovative and best performing Cannabis products and facilities. Through its subsidiaries, KNHBF has agreements in place for European-based pharmaceutical distribution, wholesale importation, research and development, as well as working interests in industrial hemp licenses in Greece, licenses to cultivate, produce, distribute, store, and export Cannabis and Cannabis derivatives in Colombia, the Kingdom of Lesotho, Africa and Denmark. Company Highlights: 110 clients representing approximately 36,300 pharmacies in 16 countries 13 hectacres of optimal agricultural land dedicated to cannabis cultivation located in Funza, Colombia 16 acres of fertile agricultural land dedicated to industrial cultivation and CBD extractuib siturated within the Greek prefecture of Imathia 2,400 pharmacies included in their distribution portfolio of independent and corporate pharmacies across South Africa 55k sq/ft fully automated IMC-GAP, ISO:9001 and European GMP compliant greenhouse facility to be constructed in Denmark 9 licenses or cultivation, spanning three continents KNHBF's Current Holdings Marathon Global Inc. Marathon Global has an exclusive agreement with Cosmos Holdings, a European based pharmaceutical distributor, to procure and distribute medical cannabis products and all cannabis derivatives for clients of Cosmos in approved countries within its distribution network of 110 clients, representing approximately 35,000 pharmacies in 16 countries. Marathon Global brings an unparalleled ability to supply the overwhelming demand for cannabis and cannabis extracts in Europe as Cosmos brings generations worth of experience and relationship to Kaneh Bosm. This distribution strategy carries on the Company’s existing distribution business through its unique BioCanna ADM retail system. EU Cannabis Corp. EU Cannabis has an option to acquire a 90-per-cent working interest in industrial hemp licenses held by Cannatec Greece A.E. Cannatech currently holds three licenses covering a total of 16 acres situated within the Greek prefecture of Imathia. These licenses were granted to Cannatec by the Hellenic Republic Ministry of Agricultural Development and Food, and permit EU Cannabis to cultivate, manufacture, distribute and export industrial hemp and its many cannabidiol (CBD) derived extracts. Greece boasts over 300 days of unadulterated sunshine per year, resulting in attractive climate for outdoor industrial hemp cultivation. The alignment of the company’s existing distribution channels, revolutionary ADM retail system along with EU Cannabis’s robust extraction capabilities will assist in appeasing an expanding appetite for functional CBD products within the European Union. Danavian Cannabis Ltd. Danavian controls licenses for cannabis cultivation and manufacturing in the Kingdom of Denmark. Kaneh Bosm’s entry into Denmark mirrors industry peers such as Canopy Growth Corporation, Green Organic Dutchman Holdings, Aurora Cannabis Inc. and CannTrust Holdings. Danavian has engaged an Israeli cannabis organic cultivation and management company, Sababa Sciences Inc. (“Sababa Sciences”). Sababa Sciences will provide end-to-end management including the implementation of advanced Israeli agricultural technologies for high quality medical cannabis treatments. Danavian and Sababa Sciences have designed a 55,000 square foot, fully automated greenhouse facility that will meet IMC-GAP, ISO:9001 and European GMP standards. Finished cannabis and cannabis derivatives produced by Danavian will be sold through Denmark’s retail pharmacy network. Danavian holds claim to premier European cannabis assets; domiciled in a jurisdiction with a highly skilled agriculture and manufacturing workforce. Davavian also boasts various industry relationships that will complement future development potential throughout Scandinavia. Continued development of Danavian’s Danish cannabis portfolio will help serve both local and export market demand. Danavian is tactically positioned in immediate proximity to Germany, allowing for direct imports of CBD products, as well as medical cannabis flower. CanAfrica Holdings CanAfrica holds a license to cultivate, manufacture, supply, hold, import, export and transport cannabis and derivative products. The Kingdom of Lesotho, Africa, has an ideal climate for low-cost greenhouse cannabis production. It averages over 300 days of sunshine annually. Lesotho was the first African nation to legalize medical cannabis in 2017. The Company believes that by establishing a presence in Africa, it will extend its current business model and allow the company to produce its own products to push through its unique and substantial European distribution networks and into its award-winning BioCanna ADM automated retail system. Aricannabis Aricannabis works on an exclusive basis with NuCare Health (“NuCare”) to provide Cannabis products to over 2,800 independent and corporate pharmacies across South Africa. NuCare also provides their medical partners with the following: Access to innovative consumer products; Strategic partnerships with key suppliers; Management of channel pressure; and Educational and training resources. The alignment of the Kaneh Bosm’s existing African cultivation capabilities and distribution channels, complemented by these new established marketing and distribution channels will augment the Company’s African seed-to-sale objectives. Cannabis Medical Group SAS Cannabis Medical Group SAS, a Colombian entity that holds licenses to cultivate, produce, hold, sell and export cannabis and cannabis derivatives. Colombia has become a highly sought-after jurisdiction for cannabis cultivation activities as it has a world-leading combination of broad public and private sector acceptance, ideal growing conditions, and a massive addressable market. Cannabis Medical Group previously acquired 13 hectares of optimal agricultural land located in Funza, the heart of the Bogota savanna, which is also one of the safest areas in Colombia. It is conveniently located within a 20-kilometre drive to Bogota’s international airport. The lease on this land has been prepaid for a period of 10 years. BioCanna ADM Retail System The BioCanna ADM retail system is an intelligent automated retail kiosk for the dispensing of Cannabis and related products in both medical and commercial markets. The BioCanna ADM retail system offers a solution to many of the concerns related to controlling access to ensure that only properly identified and qualified clients can obtain marijuana products. With strict regulations in place throughout the North American Cannabis market the BioCanna ADM could offer Cannabis retailers a means to meet and surpass regulated requirements. The BioCanna ADM retail system is unique in this sector as it encompasses the 5 crucial elements identified by Ret. Major Neill Franklin, executive director of LEAP for safe, reliable and successful automated Cannabis retail. Those elements are: Access control (no minors or un-prescribed patients) Purchase volume control (monthly or daily quantity limits) Secure storage of product (climate controlled and theft proof) Transactional oversight by regulators via software monitoring Proven track record in a controlled substance/products environment The proprietary software system, which operates the BioCanna ADM, offers regulatory bodies the ability to dynamically observe transactions in real-time at every Kiosk located within their legal jurisdiction. As you can see KNHBF is well positioned to monetize the cannabis sector from every possible angle! You would be hard pressed to find a company better positioned for growth in this multi billion dollar market than KNHBF. Recent Developments: International Cannabis Increases European Distribution Footprint by Over 1,300 Pharmacies Last week, the Company announced that its exclusive European distribution partner, Cosmos Holdings, Inc. (“Cosmos”), has acquired Greek pharmaceutical wholesaler, Cosmofarm Ltd. (“Cosmofarm”). Established in 1994, Athens based Cosmofarm provides a comprehensive range of pharmaceutical products to over 1,130 pharmacies. Cosmofarm has been authorized and endorsed by Greece’s National Organization for Medicines under Good Distribution Practices to distribute over-the-counter pharmaceuticals, natural and health food supplements, as well as branded and generic medicines. Cosmofarm is equipped with an extensive supplier network of approximately 250 pharmaceutical manufacturers and realized sales of nearly US$14 million for the fiscal year 2017. Cosmofarm is in the process of relocating its operations to a new 32,000 square foot facility, increasing its manufacturing capacities by 2,000%. The facility’s state-of-the-art manufacturing operations include a robotic fulfillment center and will significantly improve Cosmofarm’s scaling and distribution capabilities. Eugene Beukman, chief executive officer and a director of International Cannabis, stated: “International Cannabis applauds the acquisition of Cosmofarm, which further augments the Company’s robust European distribution capabilities. Cosmofarm is a rapidly growing wholesaler with embedded shared-values of innovation and high-quality distribution. This transaction is once again demonstrative of International Cannabis’ mandate of creating sustainable shareholder value, through the strategic acquisition of revenue generating assets. The Company will leverage Cosmofarm’s distribution channels and robotic fulfillment centre to facilitate its growing pipeline of purchase orders in 2019”. International Cannabis will market and sell its cannabis and cannabidiol (“CBD”) products throughout the 28 eligible member states of the European Union (“EU”). The EU has over 500 million potential consumers, affording International Cannabis a unique opportunity to service this high-growth marketplace. Furthermore, the Company plans further leverage Cosmofarm’s 32,000 square foot facility to manufacture and distribute white-labeled CBD products from its Greek industrial hemp cultivation operations. International Cannabis controls three hemp licenses spanning a total of 16 acres situated within the Greek prefecture of Imathia. These licenses permit the Company cultivate, manufacture, distribute and export industrial hemp and its many CBD derived extracts. Greece boasts over 300 days of unadulterated sunshine per year, resulting in attractive climate for outdoor industrial hemp cultivation. International Cannabis will leverage Cosmos Holdings Inc.'s robust distribution network, representing approximately 36,130 pharmacies to market and sell its cannabis and CBD products. The Company, through its wholly owned subsidiary Marathon Global Inc., has an exclusive agreement with Cosmos, a European-based pharmaceutical distributor. Cosmos has a trans-European network of over 160 clients and vendors, which expands to 16 countries, including: Germany, United Kingdom, Ireland, United Arab Emirates, Denmark, Italy, France, Singapore, Spain, Lebanon, Skopje, Jordan, Sweden, Poland, the Netherlands and Greece. This European distribution network is augmented by various value-added services, including strategic procurement, warehousing, product registrations and regulatory representations. International Cannabis, through its subsidiaries, has agreements in place for European-based pharmaceutical distribution, wholesale importation, and research and development, as well as licenses to cultivate, produce, distribute, store and export cannabis, cannabis derivatives and industrial hemp in Colombia, Denmark, Poland, Greece, Portugal, Poland, Macedonia, Bulgaria, South Africa and the Kingdom of Lesotho. Market Outlook Marijuana: A $75 Billion Market by 2030? This investment bank just increased its sales forecast for the cannabis industry by 50%. It's also a market that's expected to see continued robust sales growth. ArcView pegged North American legal-weed growth at 33% last year, to $9.7 billion, and it's forecasted $47 billion in annual sales in a decade's time. Yet even this aggressive estimate may undercut the true potential of the cannabis industry. The hemp-derived CBD market is forecast to be especially lucrative, and a 2017 report by Brightfield Group – a cannabis & CBD market research organization – predicted a per annum increase of 55% over the next five years alone. The Marijuana Industry Could be Much Bigger Than You Realize According to a new note published this past week by investment firm Cowen, the total cannabis market could generate as much as $75 billion in gross annual sales by 2030, up from a previous forecast of $50 billion by 2026. The investment bank's initial forecast was released in September 2016 via a 110-page report from beverage, tobacco, and cannabis sector analyst Vivien Azer and her team. The report, "The Cannabis Compendium: Cross-Sector Views on a Budding Industry," highlighted the many potential applications of legal cannabis and outlined pathways that would allow the weed industry to reach $50 billion in sales by 2026. Chief to that thesis is the expected legalization of marijuana in the U.S. at some point before 2026. The investment bank's new note lifts its projected sales estimate by another 50% ($25 billion), while adding on just four additional years. Cowen offered six reasons behind its decision to become even more bullish on the outlook for marijuana. Chief among them was proprietary data on binge-drinking statistics among U.S. states that showed a notable decline in binge drinking below the national average in states that had legalized cannabis. It's Cowen's assumption that as more states legalize pot, binge-drinking rates would be expected to fall as consumers opt for cannabis in place of alcohol. Additionally, Cowen finds that the cannabis market is already worth about $50 billion, albeit with black-market channels being accounted for. If you factor in per-capita spending of $1,500 a year, 50% higher than it previously forecast, along with 35 million annual cannabis users, you can see where the bulk of this $25 billion annual increase from its 2016 projections is coming from. Cowen even suggests that the United States' fight against the opioid epidemic could lead to an increase in cannabis consumption. Per the report, "Newly published research reinforces the work that we have already done, showing that for some, cannabis is an effective opioid substitute (in particular in treating chronic pain)." Technical Analysis KNHBF has never looked more attractive. Yesterday's ten percent drop in price just created the ultimate "buy the dip" opportunity for our members. KNHBF's RSI is hovering just above oversold levels, and we believe that a major bullish reversal is in the making. We also know how fast this stock can move from first hand experience. When we last brought it to your attention, shares of KNHBF made intraday swings as high as +57.39%! A run back to its 52-week of $0.90 would show our members up to +260% in pure profit! Don't miss out on KNHBF's next potential +100% rally! This is our last trade idea of 2018! And we plan on ending the year on a high note. As such, we are urging all members to act fast, start their research on KNHBF, and be ready to take action at 9:30AM EST! (*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.) Best Regards, The PennyStock101 Team Don't Miss Our Next Huge Winner... Text 'PS101' to '67076' to have our Trade Alerts Delivered Direct to your Cell Phone. (There is no charge. Msg&data rates may apply.) DISCLAIMER This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website. We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future. MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated ten thousand dollars by ICC International Cannabis Corp. to conduct investor relations advertising and marketing for KNHBF. We have been previously compensated ten thousand dollars by ICC International Cannabis Corp. to conduct investor relations advertising and marketing for KNHBF-which has expired. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
KLong
by RedHotStocks
Bitcoin Elliot wave theory + TAI have no clue when it comes to the likeliness of this drawing aligning with any future outcomes. I added some notes of my observations, for where we may be heading short term- on route to complete a medium term recovery (1-3 months). I applied some Elliot wave theory and fib retracements to further accredit trends and observations made from normal TA and patterns. It looks like bitcoin is starting to lose its bearish sentiment as seen by the broken resistance and double bottom reversal. This past pump had an extremely evident bullish divergence on the daily chart which was a strong indicator that a powerful reversal was likely. However, I don't think we are close to a bull market when considering bitcoins past value cycles, but we're getting closer to being able to say that we broke out of the free fall of sell offs. So for the next month I can see bitcoin best case scenario tapping 5300 before welcomed with a deserving correction, and worst case scenario I can see it dipping down to the 3100 level. Anything less than 3,000 in the next 3 months and I will pull out to re-enter at another sign of a reversal.
BITFINEX:BTCUSDShort
by boostedbullish
2
3 signals for $BTC reversalBeen follow the RSI and the ADX to help signal a possible reversal and was looking for 3 signals to complete this validation. 1. Divergence between the price and the RSI. As price was making a new low the RSI was signaling less sellers making that low. This is a bullish signal. 2. But what about trend momentum? We want to see a weakening bearish trend and we got that with a falling ADX line and a falling negative directional index line. 3. A move out of oversold conditions. The RSI has push higher to exit the oversold zone. Look back at history on the RSI and ADX.. when these two match the trend should reverse. I am looking for a move to the 61.8% Fibonacci level in the coming weeks. Thoughts?
BITFINEX:BTCUSDLong
by FiboSwanny
1
Simple Way to Read Oversold/Overbought Without RSIThis is how u can tell if a market is oversold (or overbought) by reading price and using our little 14EMA friend After price has a large push down (or up) like you can see in the yellow circles, it retraces up to the green circles In example 1, this yellow circle was right on the close of a huge bearish 4h engulfing. Perfect example to see how it is oversold by seeing the large gap between price and the 14 cyan coloured EMA And the following day we see this happen again in example 2. price pushes fast away from the 14EMA and therefore it needs to breath and retrace a little. No body can continuously sprint, neither can markets! "After big drop, markets must chop" Whether or not you have RSI on the charts, it is good to know when a market is oversold or overbought because nobody likes entering and seeing the trade go immediately negative, only to see it later where you thought after you closed in a loss Another cool term for a temporary up trend in an overall down trend is a dead cat bounce! This is a very very short term version considering we are looking at the 15m tf here ~ The trend is your friend and so are retracements ~
Education
by beank1
BTC/USD 1H/1D charts (12/13/2018)Good morning, traders. Bitcoin continues to move sideways as it retraced overnight and found support around the descending red previous resistance line as mentioned it was likely to do during yesterday morning's live stream. This morning, we can see price rising and, now, sitting around the McGinley Dynamic line and HVNs. Traders who were paying attention noticed the 1H bullish divergence in MACD and its histogram, noted by the blue arrow on price, and were able to profit by going long at that time. Currently, any move by price below the ascending dotted black line should have traders watching the December 11th swing low at $3292.65. A 1H close below that should have price targeting the blue December 7th TR swing low at $3210, with a 1H close below that signalling a likely test of the $3000 level. A close above the descending yellow channel that price is printing should have it targeting the 1H pivot at $3617.52. A close above that should leave price targeting the $3970-$4025 area. The 1H MACD is attempting a bullish cross at this time as well. The 1D remains the same with price printing an ascending wedge/possible bear flag within a large red descending wedge. Possible double bottom printing as well, if not the left shoulder and head of an IHS. RSI is just now peeking back out of oversold following recent bullish divergence. It has been printing higher lows toward the area of resistance around 32-33. Logically, since we are bouncing off the ascending channel's support, we would look for price to target the top of the channel. Reaching that point also puts price at the red wedge's resistance. Don't forget that a close above that resistance sets up a target of $1150 above the point at which price breaches it. Additionally, reaching that target confirms the double bottom (if an IHS doesn't play out first) thereby creating a target of $5430. If the IHS prints, then I will update with a target based on that particular pattern as well. The DXY jumped up this morning but appears to be potentially topping out. As such, it's been a volatile morning with FOREX USD pairs. I am currently long EUR/USD, but just in the short term for now as the market continues to digest this morning's ECB news, especially in relation to the recent FOMC interest rate remarks. Stocks continue to scream their weakness to anyone paying attention. Yesterday saw more of the same -- early morning buying, then distribution throughout the rest of the day. DJIA gapped up this morning but I don't believe that the market will see much bullishness out of it and I continue to see further downward momentum in the cards. Every day, we have a choice to act positively or negatively, so if you get a chance, do something decent for someone today which could be as simple as sharing a nice word with them. You just might change their day, or even their life. Remember, you can always click on the "share" button in the lower right hand of the screen, under the chart, and then click on "Make it mine" from the popup menu in order to get a live version of the chart that you can explore on your own.
BITSTAMP:BTCUSD
by Chris_Inks
RSI setting up for bull signal, but just not there yet for $BTC!I have marked with arrows each of the last 7 times the RSI for $BTC on the daily chart came up out of oversold conditions. (I have the arrows marked on the price chart too when it happened) The green arrows mark the bull signals where the market found buying interest to move the market higher to start a bull move. There were 2 red arrows where the market did not rally even with a move out of oversold conditions on the RSI. These two times had the internal momentum (ADX) still increasing strength for the bears when the break of the RSI happened. The market could not gain footing with momentum still favoring the bears. (highlighted with the red oval shows the ADX increasing with the negative directional index line in control) The other 5 times the market came out above the oversold RSI conditions (green arrows) the internal momentum for the bears was decreasing giving buying interest to the market. Where we are currently is still under the RSI line and in oversold conditions. The RSI and price have shown a divergence marked with the blue arrows, but still no move out above the green oversold RSI line. We need to see a move of the RSI line above the green oversold line and we need momentum on the ADX to start decreasing when the RSI increases. This will give a solid signal to buy and the bull trend is establishing. Otherwise we wait it out for the signals to happen and keep away from buying when the RSI stays in oversold conditions with bear momentum. If the RSI jumps up and the ADX starts to decrease at the same time then a buy signal will originate. Thoughts?
BITFINEX:BTCUSD
by FiboSwanny
4
Oversold $BTC check MTF momentum reversal for long #BitcoinOver and over again oversold conditions, coupled with high short interest are followed by a great opportunity for a long entry into BTC. Multiple Time Frame Momentum Strategy suggests that one should look for the momentum reversal to take place on multiple timeframes before entry. I like to see the following timeframes in alignment for BTCUSD. When oversold and at support it tends to move fast: 30 minute 1 hour Take larger position once the 4 hour is also in alignment We are now looking at horizontal support at $2950, and 200 week MA around $3000 as well. There should be a significant bounce off these levels in the near term. This may transpire the next time the 4-hour Stochastic RSI indicates a momentum reversal after oversold levels are measured. Metcalf's Law suggests that BTC should be at $10000 within 6 months.
BNC:BLXLong
by blloyd
The Magic Always ReturnsWe have reached the target 3200 as expected. I think the time to retest 4000, 4150 W1 EMA200 and 4400 prev high in an upwards correction will come soon as more buyers step in. SEC ETF deadline is postponed once again to Feb 27 as expected - no surprise runs any time soon. bullish: - oversold on W1 again - almost touched W1 SMA200 support - divergence forming on H1, H4, D1 RSI and H4, D1 EWO - EMA 12x26 cross on H1 and on H4 soon - seems like wave 5 of C/Y is in (could go lower though) bearish: - sell volume is rising but it is also falling compared to the first leg of the drop, so it could mean absorption before reversal - DJI/SPY can still go lower to complete an ABC correction. If SPY closes below 253 we may have a deeper correction towards W1 EMA200 (240) while going below that could mean a recession. And recession will be catastrophic for all things crypto because people will have other things to think of: mortgages and forclosures, losing their jobs, defaulting on loans, bankruptcies etc causing a domino effect. Good news: As RSI Bands show, divergence on D1 can't be invalidated - requires a drop to prev D1 RSI low 10, which translates to zero Bitcoin price - not possible. This means that we're near this year's bottom. Even if there's one more leg down, no matter how deep it is, we will definitely go up after that. Bad news: technically we could drop to 2750 first. red and green arrows represent the 2 scenarios that I see. Good Luck! Please don't trade based only on my analysis. This is not a financial advice. Do you own research to confirm.
COINBASE:BTCUSD
by RagingRocketBull
3
EURGBP: Resisted by Waning MomentumEURGBP Timeframe: H4 Direction: Short Confluences for Trade: - Waning strength in bullish rally - Price at Horizontal Resistance - Likely to Breaking S/T Trendline - Stochastic Overbought momentum - Fundamentally, both nations have internal issues that have yet to be solved, it really depends on timing on the events release; do note that EU will comment on Italy's budget tomorrow Suggested Trade: Entry @ Area of Interest 0.8890 - 0.8930 SL: 0.8969 TP: 0.8767 RR: Approx. 2.16 (Depending on Entry Level) May the pips move in our favor! Good luck! :D *This trade suggestion is provided on an advisory basis. Any trade decisions made based on this suggestion is a personal decision and we are not responsible for any losses derived from it.
Short
by weekendanalyst
EURUSD: Market Volatility PersistsEURUSD Timeframe: 1D Direction: Short Confluences for Trade: - Waning bullish momentum - Price action at Resistance of Parallel Channel - Price close to a Horizontal Resistance Line - Price reversing off a retracement of the 38.2% Fibo line - Stochastic Overbought momentum - Fundamentally, EU-Italy impasse still remains and concern about global growth outlook creating abit more volatility in the markets Suggested Trade: Entry @ Area of Interest 1.1415 - 1.1475 SL: 1.1509 TP: 1.1278 RR: Approx. 2.01 (Depending on Entry Level) May the pips move in our favor! Good luck! :D *This trade suggestion is provided on an advisory basis. Any trade decisions made based on this suggestion is a personal decision and we are not responsible for any losses derived from it.
Short
by weekendanalyst
4
Bitcoin has chosen! Now: How low will it go?So, as I feared BTC did choose not to respect the 4200 support line, that many hoped would be a magical Gandalf Mana shield barrier or something XD No, as predicted, trendlines don't count a lot in BTC, since the support is more akin to a squareroot function in the log chart. Therefore, we can go quite lower, without breaking the longterm bulltrend. The question now is how long, and when? Considern the fractal analysis with 2014/15, we're a bit slower now, lagging behind 2 months, which makes sense, since the market has grown a lot since then. It cannot be faster, because more people are in BTC, therefore the inertia is higher, BTC behaves like a physical system. We therefore can point the date of the final low to March 2019. Now, how low? Hard to see, but the super strong bulltrendline since 2010, the SQRT support, lies somewhere around 1900. Of course, it can go below that, even to 1200, and then bouncing strongly. It only depends where the weekly candle will close, and I am sure we'll see an epic bounce with insane volume on that day. How low exactly I cannot tell, but somewhere in the area 2000, and as low as 1200. Distributing the buy orders will be a very good idea then. Daily RSI is insanely oversold, we'll see an epic bounce today from 3000, the weekly might even close above 4000 again. And we see, that BTC gravitates towards the old ATHs again. Did it almost in mid 2013, did it in 2015, and probably will either do it again, or at least come very close to that region. Be prepared, and make some good profit on that day. It will be a last chance to get into BTC at these prices, before the next bullrun in 2020 starts, taking us to the top of 100K.
BNC:BLXShort
by SebastianofMoon
20
BTC: Price under SMMA + RSI over sold (under 40) = accumulate?Something I noticed on the Bitcoin 0.56% 0.69% weekly chart is that before the second and third bull run, while the price was under the SMMA ( Smoothed Moving Average ) and the RSI was oversold (under 40 in this case), it would have been a good idea to accumulate Bitcoin 0.56% 0.69% . Is this a reliable indicator for future buying opportunities? What are arguments against this theory? If you see any mistakes or anything interesting you wish to discuss, fire away. Thanks for viewing. What the freak is a smoothed average? www.danielstrading.com
BNC:BLXLong
by fifty2kph